Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GDRX GoodRx	$4.56 -1.8%	$4.75	$4.09 ▼ $9.26	$1.75B	1.25	1.48 million shs	778,126 shs
GS The Goldman Sachs Group	$585.23 +0.9%	$611.24	$387.12 ▼ $672.19	$182.51B	1.37	2.75 million shs	978,854 shs
HIMS Hims & Hers Health	$37.06 -0.9%	$39.44	$11.20 ▼ $72.98	$8.20B	1.37	22.63 million shs	13.61 million shs
MS Morgan Stanley	$125.00 +0.6%	$130.56	$85.01 ▼ $142.03	$201.47B	1.35	7.21 million shs	2.52 million shs
ULTA Ulta Beauty	$370.95 +1.3%	$376.82	$309.01 ▼ $529.67	$17.20B	1.34	1.04 million shs	575,820 shs
XLY Consumer Discretionary Select Sector SPDR Fund	$205.39 +0.5%	$218.00	$166.48 ▼ $240.28	$21.39B	1.25	3.28 million shs	2.55 million shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GDRX GoodRx	0.00%	+4.04%	-3.53%	+3.34%	-29.48%
GS The Goldman Sachs Group	+2.85%	+5.35%	-7.13%	-0.29%	+42.84%
HIMS Hims & Hers Health	+7.48%	+7.75%	-23.89%	+32.74%	+128.82%
MS Morgan Stanley	+3.43%	+5.22%	-5.49%	-2.11%	+35.27%
ULTA Ulta Beauty	+4.45%	+2.57%	+1.28%	-15.89%	-29.63%
XLY Consumer Discretionary Select Sector SPDR Fund	+3.46%	+3.70%	-6.46%	-12.87%	+11.80%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GDRX GoodRx	3.5101 of 5 stars	3.4	3.0	0.0	0.0	3.7	1.7	1.9
GS The Goldman Sachs Group	4.9042 of 5 stars	2.2	3.0	4.2	3.0	2.7	3.3	3.8
HIMS Hims & Hers Health	2.2319 of 5 stars	2.1	2.0	0.0	0.0	2.1	3.3	1.9
MS Morgan Stanley	4.519 of 5 stars	2.2	3.0	4.2	2.4	2.2	2.5	2.5
ULTA Ulta Beauty	4.5518 of 5 stars	3.2	4.0	0.0	1.8	4.0	1.7	2.5
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GDRX GoodRx	2.80	Moderate Buy	$8.18	79.47% Upside
GS The Goldman Sachs Group	2.44	Hold	$593.27	1.37% Upside
HIMS Hims & Hers Health	2.27	Hold	$37.31	0.67% Upside
MS Morgan Stanley	2.33	Hold	$132.33	5.87% Upside
ULTA Ulta Beauty	2.46	Hold	$427.13	15.14% Upside
XLY Consumer Discretionary Select Sector SPDR Fund	2.67	Moderate Buy	$204.72	-0.33% Downside

Current Analyst Ratings Breakdown

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/25/2025	GS The Goldman Sachs Group	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$605.00 ➝ $625.00
3/25/2025	MS Morgan Stanley	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$124.00 ➝ $129.00
3/24/2025	GS The Goldman Sachs Group	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$585.00 ➝ $550.00
3/24/2025	MS Morgan Stanley	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$135.00 ➝ $125.00
3/19/2025	GS The Goldman Sachs Group	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
3/19/2025	MS Morgan Stanley	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$144.00 ➝ $126.00
3/18/2025	HIMS Hims & Hers Health	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$21.00 ➝ $22.00
3/17/2025	MS Morgan Stanley	Erste Group Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
3/17/2025	ULTA Ulta Beauty	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$405.00 ➝ $365.00
3/14/2025	ULTA Ulta Beauty	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$445.00 ➝ $327.00
3/14/2025	ULTA Ulta Beauty	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Perform ➝ Market Perform	$467.00 ➝ $404.00

(Data available from 3/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GDRX GoodRx	$792.32M	2.21	$0.39 per share	11.77	$1.93 per share	2.36
GS The Goldman Sachs Group	$53.51B	3.41	$37.37 per share	15.66	$324.13 per share	1.81
HIMS Hims & Hers Health	$1.48B	5.58	N/A	N/A	$1.61 per share	23.02
MS Morgan Stanley	$57.62B	3.50	$7.83 per share	15.97	$55.58 per share	2.25
ULTA Ulta Beauty	$11.30B	1.52	$31.98 per share	11.60	$46.94 per share	7.90
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GDRX GoodRx	-$8.87M	$0.05	N/A	25.31	2.46	-2.05%	5.35%	2.51%	5/8/2025 (Estimated)
GS The Goldman Sachs Group	$14.28B	$40.55	14.42	11.24	0.89	11.32%	13.30%	0.84%	4/21/2025 (Estimated)
HIMS Hims & Hers Health	-$23.55M	$0.54	83.92	71.27	N/A	8.19%	10.97%	8.29%	5/5/2025 (Estimated)
MS Morgan Stanley	$13.39B	$7.94	15.73	13.26	1.18	12.48%	14.39%	1.09%	4/15/2025 (Estimated)
ULTA Ulta Beauty	$1.29B	$25.37	14.84	15.68	0.89	10.58%	51.95%	20.88%	5/29/2025 (Estimated)
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	24.10	∞	N/A	N/A	N/A	N/A	N/A

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/21/2025	N/A	GS The Goldman Sachs Group	$12.57	N/A	N/A	N/A	$14.99 billion	N/A
4/15/2025	N/A	MS Morgan Stanley	$2.22	N/A	N/A	N/A	$16.81 billion	N/A
3/13/2025	Q4 2025	ULTA Ulta Beauty	$7.13	$8.46	+$1.33	$8.46	$3.47 billion	$3.49 billion
2/24/2025	Q4 2024	HIMS Hims & Hers Health	$0.09	$0.11	+$0.02	$0.11	$494.56 million	$481.14 million
1/16/2025	Q4 24	MS Morgan Stanley	$1.54	$2.22	+$0.68	$2.22	$15.03 billion	$16.23 billion
1/15/2025	Q4 2024	GS The Goldman Sachs Group	$8.21	$11.95	+$3.74	$11.95	$12.36 billion	$13.87 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GDRX GoodRx	N/A	N/A	N/A	N/A	N/A
GS The Goldman Sachs Group	$12.00	2.05%	+20.95%	29.59%	13 Years
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
MS Morgan Stanley	$3.70	2.96%	+19.13%	46.60%	12 Years
ULTA Ulta Beauty	N/A	N/A	N/A	N/A	N/A
XLY Consumer Discretionary Select Sector SPDR Fund	$1.62	0.79%	N/A	N/A	N/A

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/15/2025	GS The Goldman Sachs Group	quarterly	$3.00	2%	2/28/2025	2/28/2025	3/28/2025
1/9/2025	XLY Consumer Discretionary Select Sector SPDR Fund		$0.5420		3/24/2025	3/24/2025	3/26/2025
1/9/2025	XLY Consumer Discretionary Select Sector SPDR Fund		$0.5420		3/24/2025	3/24/2025	3/26/2025
1/16/2025	MS Morgan Stanley	quarterly	$0.9250	2.82%	1/31/2025	1/31/2025	2/14/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GDRX GoodRx	0.70	5.48	5.48
GS The Goldman Sachs Group	2.32	0.67	0.67
HIMS Hims & Hers Health	N/A	2.14	1.82
MS Morgan Stanley	3.14	0.80	0.80
ULTA Ulta Beauty	N/A	1.63	0.32
XLY Consumer Discretionary Select Sector SPDR Fund	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GDRX GoodRx	63.77%
GS The Goldman Sachs Group	71.21%
HIMS Hims & Hers Health	63.52%
MS Morgan Stanley	84.19%
ULTA Ulta Beauty	90.39%
XLY Consumer Discretionary Select Sector SPDR Fund	69.93%

Insider Ownership

Company	Insider Ownership
GDRX GoodRx	4.17%
GS The Goldman Sachs Group	0.54%
HIMS Hims & Hers Health	17.71%
MS Morgan Stanley	0.24%
ULTA Ulta Beauty	0.39%
XLY Consumer Discretionary Select Sector SPDR Fund	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GDRX GoodRx	950	383.61 million	365.25 million	Optionable
GS The Goldman Sachs Group	45,300	312.04 million	310.35 million	Optionable
HIMS Hims & Hers Health	650	222.17 million	179.79 million	Optionable
MS Morgan Stanley	80,000	1.61 billion	1.61 billion	Optionable
ULTA Ulta Beauty	40,500	46.37 million	46.19 million	Optionable
XLY Consumer Discretionary Select Sector SPDR Fund	147,000	104.20 million	N/A	Not Optionable

XLY, HIMS, GS, MS, GDRX, and ULTA Headlines

Recent News About These Companies

Weekly Economic Snapshot: Inflation Relief Tempered by Sentiment Concerns

March 17, 2025 | etftrends.com

Consumer Staples ETFs: Defensive Strength in Uncertain Times

March 13, 2025 | etftrends.com

3 Stocks Institutions Are Quietly Dumping (XLY)

March 11, 2025 | marketbeat.com

"Chaos Creates Opportunities"? Buy These ETFs

March 10, 2025 | zacks.com

How Is Starbucks’ Stock Performance Compared to Other Consumer Discretionary Stocks?

March 6, 2025 | msn.com

Shares of XLY Now Oversold

March 6, 2025 | nasdaq.com

XLY: Avoid The Worst Performer

March 3, 2025 | seekingalpha.com

Weekly Economic Snapshot: Inflation Concerns Cast Shadow of Uncertainty

March 3, 2025 | etftrends.com

Sector Rotation Taking Hold as Healthcare Surges, Financials Lag

February 27, 2025 | ca.investing.com

Amazon.com Stock: Is AMZN Outperforming the Consumer Cyclical Sector?

February 27, 2025 | msn.com

Weekly Economic Snapshot: Confidence Falls, Housing Stumbles, and Uncertainty Grows

February 24, 2025 | etftrends.com

Weekly Economic Snapshot: Jobs, Inflation, & Sentiment Keep Markets on Edge

February 10, 2025 | etftrends.com

9 out of 12 S&P 500 consumer discretionary stocks deliver EPS wins this week - Earnings Scorecard

February 8, 2025 | msn.com

Consumer Discretionary Stocks Soar But Is a Pullback Looming? (XLY)

February 5, 2025 | marketbeat.com

Weekly Economic Snapshot: Growth, Inflation, and Confidence Amid Market Volatility

February 3, 2025 | etftrends.com

MarketBeat Week in Review – 01/27 - 01/31 (XLY)

February 1, 2025 | marketbeat.com

Should You Invest in the Consumer Discretionary Select Sector SPDR ETF (XLY)?

January 30, 2025 | zacks.com

Should You Invest in the Consumer Discretionary Select Sector SPDR ETF (XLY)?

January 30, 2025 | zacks.com

A Pivotal Moment for the Consumer Discretionary Sector (XLY)

January 27, 2025 | marketbeat.com

Weekly Economic Snapshot: Signs of Strength & Softness

January 27, 2025 | etftrends.com

Q4 Earnings Show Promise: Sector ETFs to Win

January 24, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Price Targets on NVIDIA Rise in Front of Earnings
By Sarah Horvath | February 24, 2025
View Price Targets on NVIDIA Rise in Front of Earnings
Archer Aviation Stock Skids: Mistaking Progress for Bad News?
By Chris Markoch | February 24, 2025
View Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Volatility Is Back: 3 Stocks To Cushion the S&P 500's Swings
By Gabriel Osorio-Mazilli | February 27, 2025
View Volatility Is Back: 3 Stocks To Cushion the S&P 500's Swings
Finding Hidden Gems: Unconventional Penny Stock Investing
By Dan Schmidt | February 24, 2025
View Finding Hidden Gems: Unconventional Penny Stock Investing
Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
By Ryan Hasson | February 25, 2025
View Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?

XLY, HIMS, GS, MS, GDRX, and ULTA Company Descriptions

GoodRx NASDAQ:GDRX

$4.56 -0.09 (-1.83%)

As of 03:38 PM Eastern

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

The Goldman Sachs Group NYSE:GS

$585.23 +5.13 (+0.88%)

As of 03:38 PM Eastern

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Hims & Hers Health NYSE:HIMS

$37.06 -0.35 (-0.94%)

As of 03:38 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Morgan Stanley NYSE:MS

$125.00 +0.73 (+0.59%)

As of 03:38 PM Eastern

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services. The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions. The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels. The company was founded in 1924 and is headquartered in New York, New York.

Ulta Beauty NASDAQ:ULTA

$370.95 +4.79 (+1.31%)

As of 03:38 PM Eastern

Ulta Beauty, Inc. operates as a specialty beauty retailer in the United States. The company offers branded and private label beauty products, including cosmetics, fragrance, haircare, skincare, bath and body products, professional hair products, and salon styling tools through its Ulta Beauty stores, shop-in-shops, Ulta.com website, and its mobile applications. It also offers beauty services, including hair, makeup, brow, and skin services at its stores. The company was formerly known as ULTA Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

$205.39 +1.10 (+0.54%)

As of 03:38 PM Eastern

Consumer Discretionary Select Sector SPDR Fund seeks to provide investment results that correspond generally to the price and yield performance of the Consumer Discretionary Select Sector Index (the Index). The Index includes companies from the following industries, media; retail (specialty, multiline, Internet and catalog); hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure equipment and products; and diversified consumer services. The Fund's investment advisor is SSgA Funds Management, Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Earnings

Compare Dividends

Latest XLY, HIMS, GS, MS, GDRX, and ULTA Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

XLY, HIMS, GS, MS, GDRX, and ULTA Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

XLY, HIMS, GS, MS, GDRX, and ULTA Company Descriptions

GoodRx NASDAQ:GDRX

The Goldman Sachs Group NYSE:GS

Hims & Hers Health NYSE:HIMS

Morgan Stanley NYSE:MS

Ulta Beauty NASDAQ:ULTA

Consumer Discretionary Select Sector SPDR Fund NYSEARCA:XLY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools